Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB252225

Myeloid-Associated Differentiation Marker Antibody (MYADM/971), PE, Novus Biologicals™
SDP

Catalog No. NB252225 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB252225 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB252225 Supplier Novus Biologicals Supplier No. NBP311489PE
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Myeloid-Associated Differentiation Marker Monoclonal antibody specifically detects Myeloid-Associated Differentiation Marker in Human, Macaque samples. It is validated for Flow Cytometry

Specifications

Antigen Myeloid-Associated Differentiation Marker
Applications Flow Cytometry
Classification Monoclonal
Clone MYADM/971
Conjugate PE
Dilution Flow Cytometry
Formulation PBS
Gene Alias MYADM, Myeloid Upregulated Protein, Protein SB135, SB135
Host Species Mouse
Immunogen Recombinant full-length human Myeloid-Associated Differentiation Marker protein. (Uniprot: Q96S97)
Purification Method Protein A or G purified
Quantity 0.1 mL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 91663
Target Species Human, Macaque
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG1 κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.